`
`In the Inter Partes Review of:
`
`Trial Number: To Be Assigned
`
`U.S. Patent No. 9,187,405
`
`Filed: April 21, 2014
`
`Issued: November 17, 2015
`
`Inventor(s): Peter C. Hiestand, Christian
`Schnell
`
`Assignee: Novartis A.G.
`
`Title: S 1 P receptor modulators for treating
`relapsing-remitting multiple sclerosis
`
`Panel: To Be Assigned
`
`Mail Stop Inter Partes Review
`Commissions for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`PETITIONERS ACT A VIS ELIZABETH LLC AND TEVA
`PHARMACEUTICALS USA, INC.'S POWER OF ATTORNEY
`IN AN INTER PARTES REVIEW
`
`Petitioners Actavis Elizabeth LLC and Teva Pharmaceuticals USA, Inc.
`
`hereby appoint the following practitioners as their attorneys to transact all business
`
`in the United States Patent & Trademark Office associated with the above-
`
`captioned inter partes review:
`
`Amanda Hollis (Reg. No. 55629)
`amanda.hollis@kirkland.com
`Postal and Hand-Delivery Address:
`KIRKLAND & ELLIS LLP
`300 North LaSalle Street
`
`
`
`Chicago, Illinois 60654
`Telephone: (312) 862-2000
`Facsimile: (312) 862-2200
`Gregory Springsted
`greg.springsted@kirkland.com
`Postal and Hand-Delivery Address:
`KIRKLAND & ELLIS LLP
`60 l Lexington A venue
`New York, New York 10022
`Telephone: (212) 446-4800
`Fax: (212) 446-4900
`
`The individual signing below has the authority to execute this document on
`
`behalf of Actavis Elizabeth LLC and Teva Pharmaceuticals USA, Inc.
`
`Date: Av-.s 1 V, d9l 7
`
`Name: Lauren Rabinovic
`Title: Vice President and General Counsel
`North Americas Generic IP
`Teva Pharmaceuticals
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. §§ 42.6(e) and 42.105(a), this is to certify that I
`
`caused to be served a true and correct copy of the foregoing Petitioners Actavis
`
`Elizabeth LLC and Teva Pharmaceuticals USA, Inc.’s Power of Attorney in an
`
`Inter Partes Review by overnight courier (Federal Express), on this 15th day of
`
`August, 2017, on the Patent Owner at the correspondence address of the Patent
`
`Owner as follows:
`
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`One Health Plaza 433/2
`East Hanover, NJ 07936-1080
`A courtesy copy of the foregoing was also served via email on the counsel of
`
`record for the Petitioner and Patent Owner in the Apotex IPR, IPR2017-00854, and
`
`the Argentum IPR, IPR2017-01550 as follows:
`
`IPR2017-00854 Petitioner
`Steve Parmelee
`Michael Rosato
`Jad A. Mills
`Wilson Sonsini Goodrich & Rosati
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`
`IPR2017-01550 Petitioner
`Terry Rea
`Deborah H. Yellin
`Shannon Lentz
`
`Patent Owner
`Jane M. Love
`Robert W. Trenchard
`Gibson, Dunn & Crutcher LLP
`200 Park Avenue
`New York, NY 10166-0193
`jlove@gibsondunn.com
`rtrenchard@gibsondunn.com
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/s/ Amanda Hollis
`Amanda Hollis (Reg. No. 55,629)
`KIRKLAND & ELLIS LLP
`300 North LaSalle
`Chicago, IL 60654
`Telephone: (312) 862-2000
`Facsimile: (312) 862-2200
`amanda.hollis@kirkland.com
`
`Attorney for Petitioners
`
`1001 Pennsylvania Avenue, NW
`Washington, DC 20004-2595
`trea@crowell.com
`dyellin@crowell.com
`slentz@crowell.com
`
`Tyler C. Liu
`Argentum Pharmaceuticals, LLC
`tliu@agpharm.com
`
`
`Dated: August 15, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`